Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
127,672,444
-
Total 13F shares
-
15,746,683
-
Share change
-
+15,746,683
-
Total reported value
-
$340,174,825
-
Price per share
-
$21.70
-
Number of holders
-
46
-
Value change
-
+$340,174,875
-
Number of buys
-
46
Institutional Holders of Apellis Pharmaceuticals, Inc. - Common Stock (APLS) as of Q4 2017
As of 31 Dec 2017,
Apellis Pharmaceuticals, Inc. - Common Stock (APLS) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,746,683 shares.
The largest 10 holders included
Cormorant Asset Management, LLC, Sectoral Asset Management Inc, Vivo Capital, LLC, Hillhouse Capital Management, Ltd., EcoR1 Capital, LLC, BlackRock Inc., CLOUGH CAPITAL PARTNERS L P, RA CAPITAL MANAGEMENT, LLC, JENNISON ASSOCIATES LLC, and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C).
This page lists
46
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.